(Q40361526)

19 September 2017

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever (English)

1 reference

19 September 2017

1 reference

1 reference

Nilüfer Alpay

1

1 reference

19 September 2017

Abdullah Sumnu

2

1 reference

19 September 2017

Yaşar Calışkan

3

1 reference

19 September 2017

Halil Yazıcı

4

1 reference

19 September 2017

Aydın Türkmen

5

1 reference

19 September 2017

Ahmet Gül

6

1 reference

19 September 2017

13 April 2010

1 reference

Rheumatology International

19 September 2017

1 reference

19 September 2017

32

1 reference

19 September 2017

10

1 reference

19 September 2017

3277-3279

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-010-1474-6

19 September 2017

0 references

cites work

Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization

1 reference

12 December 2020

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever

1 reference

12 December 2020

The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial

1 reference

12 December 2020

Familial Mediterranean fever successfully treated with etanercept.

1 reference

12 December 2020

The spectrum of Familial Mediterranean Fever (FMF) mutations

1 reference

12 December 2020

Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever

1 reference

12 December 2020

Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra

1 reference

12 December 2020

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

1 reference

12 December 2020

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production

1 reference

12 December 2020

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

10.1007/S00296-010-1474-6

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference